BioCentury | Mar 18, 2002
Finance

Ebb & Flow

...Friday before last. DoubleTwist is the latest failure in the online life science portal game. eBioinformatics...
BioCentury | Jan 14, 2002
Finance

Hat in Hand?

...$12.0M Withdrew IPO on 11/01 Xanthon $12.0M Pharmadigm $12.0M Metabolex $10.8M GeneMachines $10.7M Maxia $10.0M eBioinformatics...
BioCentury | Aug 27, 2001
Finance

Money Hunters

...$12.0M Filed for IPO 3/2/01 Xanthon $12.0M Pharmadigm $12.0M Metabolex $10.8M GeneMachines $10.7M Maxia $10.0M eBioinformatics...
BioCentury | Aug 27, 2001
Finance

Money Hunters

...$12.0M Filed for IPO 3/2/01 Xanthon $12.0M Pharmadigm $12.0M Metabolex $10.8M GeneMachines $10.7M Maxia $10.0M eBioinformatics...
BioCentury | Dec 18, 2000
Company News

eBioinformatics, Empatheon Inc. deal

...The companies merged to create Entigen Corp. (Sunnyvale, Calif.), which will integrate eBioinformatics’ internet BioNavigator service...
...management system that integrates biologic data from disparate sources in real time. (Entigen board, B10) eBioinformatics Inc....
BioCentury | Dec 13, 2000
Company News

eBioinformatics merges with Empatheon

...and Empatheon (Sunnyvale, Calif.) merged to create Entigen (Sunnyvale, Calif.). The new company will integrate eBioinformatics'...
BioCentury | Nov 13, 2000
Finance

IBT's investments

...Therap (CTIC) $15.0M CeNeS (LSE:CEN) 2.0M (US$3.1M) Corixa (CRXA) $5.0M Corvas (CVAS) $7.6M Delsys $10.0M eBioinformatics...
BioCentury | Sep 18, 2000
Company News

eBioinformatics, Qiagen deal

...Inc. subsidiary (Alameda, Calif.). The combined service will be available to each company's respective customers. eBioinformatics Inc....
BioCentury | Sep 14, 2000
Company News

eBioinformatics deal with Qiagen subsidiary

eBioinformatics (Pleasanton, Calif.) will combine its online DNA primer design application with the custom DNA synthesis and delivery service of Operon Technologies, a subsidiary Qiagen (NMarkt:QIA; QGENF). BC Staff...
BioCentury | May 30, 2000
Finance

ASCO's damp squib

...delivery technology uses nanoparticles to deliver anticancer and other drugs to drug-resistant patients (see B19). eBioinformatics...
Items per page:
1 - 10 of 15
BioCentury | Mar 18, 2002
Finance

Ebb & Flow

...Friday before last. DoubleTwist is the latest failure in the online life science portal game. eBioinformatics...
BioCentury | Jan 14, 2002
Finance

Hat in Hand?

...$12.0M Withdrew IPO on 11/01 Xanthon $12.0M Pharmadigm $12.0M Metabolex $10.8M GeneMachines $10.7M Maxia $10.0M eBioinformatics...
BioCentury | Aug 27, 2001
Finance

Money Hunters

...$12.0M Filed for IPO 3/2/01 Xanthon $12.0M Pharmadigm $12.0M Metabolex $10.8M GeneMachines $10.7M Maxia $10.0M eBioinformatics...
BioCentury | Aug 27, 2001
Finance

Money Hunters

...$12.0M Filed for IPO 3/2/01 Xanthon $12.0M Pharmadigm $12.0M Metabolex $10.8M GeneMachines $10.7M Maxia $10.0M eBioinformatics...
BioCentury | Dec 18, 2000
Company News

eBioinformatics, Empatheon Inc. deal

...The companies merged to create Entigen Corp. (Sunnyvale, Calif.), which will integrate eBioinformatics’ internet BioNavigator service...
...management system that integrates biologic data from disparate sources in real time. (Entigen board, B10) eBioinformatics Inc....
BioCentury | Dec 13, 2000
Company News

eBioinformatics merges with Empatheon

...and Empatheon (Sunnyvale, Calif.) merged to create Entigen (Sunnyvale, Calif.). The new company will integrate eBioinformatics'...
BioCentury | Nov 13, 2000
Finance

IBT's investments

...Therap (CTIC) $15.0M CeNeS (LSE:CEN) 2.0M (US$3.1M) Corixa (CRXA) $5.0M Corvas (CVAS) $7.6M Delsys $10.0M eBioinformatics...
BioCentury | Sep 18, 2000
Company News

eBioinformatics, Qiagen deal

...Inc. subsidiary (Alameda, Calif.). The combined service will be available to each company's respective customers. eBioinformatics Inc....
BioCentury | Sep 14, 2000
Company News

eBioinformatics deal with Qiagen subsidiary

eBioinformatics (Pleasanton, Calif.) will combine its online DNA primer design application with the custom DNA synthesis and delivery service of Operon Technologies, a subsidiary Qiagen (NMarkt:QIA; QGENF). BC Staff...
BioCentury | May 30, 2000
Finance

ASCO's damp squib

...delivery technology uses nanoparticles to deliver anticancer and other drugs to drug-resistant patients (see B19). eBioinformatics...
Items per page:
1 - 10 of 15